These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 16728939)

  • 1. Chemotherapy in the management of cervical carcinoma.
    duPont NC; Monk BJ
    Clin Adv Hematol Oncol; 2006 Apr; 4(4):279-86. PubMed ID: 16728939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy for recurrent cervical cancer.
    Pectasides D; Kamposioras K; Papaxoinis G; Pectasides E
    Cancer Treat Rev; 2008 Nov; 34(7):603-13. PubMed ID: 18657909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
    Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined-modality therapy of locally advanced cervical cancer.
    Rose PG
    J Clin Oncol; 2003 May; 21(10 Suppl):211s-217s. PubMed ID: 12743137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directions.
    Monk BJ; Tewari KS; Koh WJ
    J Clin Oncol; 2007 Jul; 25(20):2952-65. PubMed ID: 17617527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy for recurrent cervical cancer.
    Cadron I; Van Gorp T; Amant F; Leunen K; Neven P; Vergote I
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S113-8. PubMed ID: 17804044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study.
    Rose PG; Ali S; Watkins E; Thigpen JT; Deppe G; Clarke-Pearson DL; Insalaco S;
    J Clin Oncol; 2007 Jul; 25(19):2804-10. PubMed ID: 17502627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of chemotherapy in locally advanced, metastatic and recurrent cervical cancer.
    Tambaro R; Scambia G; Di Maio M; Pisano C; Barletta E; Iaffaioli VR; Pignata S
    Crit Rev Oncol Hematol; 2004 Oct; 52(1):33-44. PubMed ID: 15363465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent achievements and future developments in advanced and recurrent cervical cancer: trials of the Gynecologic Oncology Group.
    Tewari KS; Monk BJ
    Semin Oncol; 2009 Apr; 36(2):170-80. PubMed ID: 19332251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy for recurrent and metastatic cervical cancer.
    Tao X; Hu W; Ramirez PT; Kavanagh JJ
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S67-71. PubMed ID: 18533239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel chemotherapy approaches in chemoradiation protocols.
    González-Cortijo L; Carballo N; González-Martín A; Corraliza V; Chiva de Agustín L; Lapuente Sastre F; García García JF; Rojo Sebastián A; Hornedo J; Colomer R
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S45-8. PubMed ID: 18678399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined radiation therapy and chemotherapy for carcinoma of the cervix.
    Rose PG; Eifel PJ
    Cancer J; 2001; 7(2):86-94. PubMed ID: 11324770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life and treatment related toxicity in 335 patients with locally advanced cervical carcinoma treated by two chemoradiation regimens.
    Nagy V; Todor N; Coza O; Ordeanu C; Ghilezan N
    J BUON; 2007; 12(3):389-94. PubMed ID: 17918294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in cervical carcinoma limited to the pelvis: a phase I/II study of the Gynecologic Oncology Group.
    DiSilvestro PA; Walker JL; Morrison A; Rose PG; Homesley H; Warshal D;
    Gynecol Oncol; 2006 Dec; 103(3):1038-42. PubMed ID: 16889823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weekly systemic cisplatin plus locoregional hyperthermia: an effective treatment for patients with recurrent cervical carcinoma in a previously irradiated area.
    Franckena M; De Wit R; Ansink AC; Notenboom A; Canters RA; Fatehi D; Van Rhoon GC; Van Der Zee J
    Int J Hyperthermia; 2007 Aug; 23(5):443-50. PubMed ID: 17701535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy for women with locally advanced carcinoma of the uterine cervix--final results of a prospective phase II-study.
    Vrdoljak E; Omrcen T; Novaković ZS; Jelavić TB; Prskalo T; Hrepić D; Hamm W
    Gynecol Oncol; 2006 Nov; 103(2):494-9. PubMed ID: 16814371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome for chemoradiotherapy in carcinoma of the cervix.
    Spensley S; Hunter RD; Livsey JE; Swindell R; Davidson SE
    Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):49-55. PubMed ID: 19081712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoma of the uterine cervix: current status and future directions.
    Thigpen T; Vance RB; Khansur T
    Semin Oncol; 1994 Apr; 21(2 Suppl 2):43-54; quiz 55, 58. PubMed ID: 8202720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of topotecan to standard cisplatin/etoposide combination in patients with extended stage small cell lung carcinoma.
    Tas F; Derin D; Guney N; Camlica H; Aydiner A; Topuz E
    Lung Cancer; 2007 Jul; 57(1):79-83. PubMed ID: 17383768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of metastatic cervical cancer: review of the literature.
    Long HJ
    J Clin Oncol; 2007 Jul; 25(20):2966-74. PubMed ID: 17617528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.